Description
About Viraday:
Viraday, manufactured by Cipla Ltd., is a comprehensive antiretroviral medication designed for the treatment of HIV-1 infection in adults. It combines three potent antiretroviral agents – Efavirenz, Tenofovir, and Emtricitabine – into a single tablet regimen, simplifying treatment and enhancing patient adherence. This triple combination therapy targets different stages of the HIV lifecycle, effectively suppressing viral replication and helping to control the progression of HIV disease.
Key Features:
- Triple Antiretroviral Therapy: Viraday contains a combination of Efavirenz, Tenofovir, and Emtricitabine, offering potent and synergistic antiretroviral activity against HIV-1.
- Comprehensive Strength: Each tablet of Viraday provides a fixed dose of Efavirenz 600 mg, Tenofovir 300 mg, and Emtricitabine 200 mg, ensuring consistent and effective treatment outcomes.
- Targeted HIV Suppression: The components of Viraday act through different mechanisms to inhibit viral replication, including inhibition of reverse transcriptase activity and incorporation into viral DNA, ultimately reducing viral load and preserving immune function.
- Manufactured by Cipla Ltd.: Viraday is manufactured by Cipla Ltd., a reputable pharmaceutical company known for its commitment to quality, affordability, and accessibility of HIV/AIDS medications.
- Clinically Proven Efficacy: The efficacy and safety of Viraday have been demonstrated in clinical trials, establishing it as a preferred regimen for the management of HIV-1 infection in adults.
- Convenient Tablet Formulation: Viraday tablets are formulated for oral administration, providing patients with a convenient and discreet dosing option for long-term HIV therapy.
Indications:
Viraday (Efavirenz, Tenofovir & Emtricitabine Tablets) is indicated for the treatment of:
- HIV-1 infection in adults, either treatment-naive or as a switch therapy in patients virologically suppressed on a stable antiretroviral regimen.
Usage Directions:
Viraday tablets should be taken orally once daily, with or without food, as directed by a qualified healthcare professional experienced in the management of HIV infection. The prescribed dosage and duration of treatment may vary based on individual patient factors, including prior treatment history, viral resistance profile, and concomitant medications. It is essential to follow the prescribing physician’s instructions closely and complete the full course of treatment for optimal therapeutic outcomes.
Storage Information:
- Store Viraday tablets in the original packaging at room temperature (20°C to 25°C), away from moisture and heat.
- Keep out of reach of children and pets.
Caution:
- Viraday should be used with caution in patients with pre-existing renal impairment or bone mineral density abnormalities, as Tenofovir may exacerbate these conditions.
- Close monitoring of renal function, liver enzymes, and HIV viral load is recommended during Viraday therapy to ensure treatment efficacy and safety.
Availability:
Viraday (Efavirenz, Tenofovir & Emtricitabine Tablets) is available by prescription only and can be obtained from authorized healthcare facilities and pharmacies.
Disclaimer:
The information provided herein is for informational purposes only and should not be construed as medical advice or a substitute for professional medical consultation. Patients should consult their healthcare providers regarding diagnosis, treatment, and potential side effects associated with Viraday therapy.
Reviews
There are no reviews yet.